As global markets grapple with inflation fluctuations and trade policy uncertainties, Asian tech stocks have emerged as a focal point for investors seeking growth opportunities amid broader market ...
Publication of SARA-INT Phase II results for BIO101Confirmation of Phase 3 readinessParis, France and Cambridge, Massachusetts--(Newsfile Corp. - March 17, 2025) - Biophytis SA (FP: ALBPS) ("Biophytis ...
Scientists at the Garvan Institute of Medical Research have found that pancreatic cancer uses a key metabolic switch to help ...
News-Medical.Net on MSN4d
Neuropeptide Y identified as key driver of pancreatic cancer spreadResearchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ...
In this video, John O. Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care.
Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ...
GlobalData on MSN4d
Anocca gains European authorisation for Phase I/II trial of pancreatic cancer drugAnocca has secured authorisation from regulatory authorities in four European nations for its Phase I/II VIDAR-1 clinical ...
Dr. Wei-Hua Chen, a renowned 70-year-old cardiologist and the director of Hongxin Clinic (Taichung, Taiwan), has been awarded the '28th Fervent Global Love of Lives Award 2025' by the Chou Ta-Kuan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback